Endocrine and metabolic disorders in cancer patients

Abstract

Endocrine and metabolic disorders can occur in the form of paraneoplastic syndrome and as a consequence of oncological treatment. The most common disorders include hypercalcaemia, ectopic production of vasopressin in the course of cancer, ectopic Cushing’s syndrome and secondary osteoporosis. What should be taken into account during the diagnosis of endocrine disorders, is paraneoplastic syndrome that frequently precedes the occurrence of symptoms typical of a particular diagnosis, which could influence the proper orientation of the diagnostic process. During and after anticancer treatment, it is recommended that patients should be monitored for the possible development of acute or chronic metabolic and endocrine disorders which may pose a threat to their life or health.